You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 6, June 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture

J. A. Shields, C. L. Shields and P. De Potter
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pa, USA.

To our knowledge, there are no articles that describe the specific step-by-step details of the surgical removal of premalignant and malignant conjunctival tumors. We describe our current approach to the surgical management of squamous cell carcinoma (intraepithelial or invasive), localized melanoma, and primary acquired melanosis of the conjunctiva. The surgical method differs with limbal tumors, extralimbal tumors, and primary acquired melanosis. Limbal lesions are managed by localized alcohol corneal epitheliectomy, removal of the main mass by a partial lamellar scleroconjunctivectomy, and supplemental cryotherapy. Tumors located in the extralimbal conjunctiva are managed by alcohol application, wide circumferential surgical resection, and cryotherapy. Primary acquired melanosis is managed by alcohol epitheliectomy, removal of suspicious foci, quadrantic staging biopsies, and cryotherapy from the underside of the conjunctiva. In all cases, a "no touch" method is used and direct manipulation of the tumor is avoided to prevent tumor cell seeding into a new area. We have employed this technique on 109 patients with conjunctival squamous neoplasms and 137 patients with conjunctival melanoma, about 80 of which neoplasms were associated with primary acquired melanosis. Our observations suggest that well-planned initial surgical management using this technique decreases the chance of tumor recurrence for conjunctival melanoma and squamous cell carcinoma. We describe a detailed stepwise approach to the surgical management of conjunctival neoplasms. It requires meticulous clinical evaluation and complete removal of the tumor in one operation using a specific technique.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Report of a conjunctival myxoma case and review of the literature.
Demirci et al.
Arch Ophthalmol 2006;124:735-738.
FULL TEXT  

Chemoreduction With Topical Mitomycin C Prior to Resection of Extensive Squamous Cell Carcinoma of the Conjunctiva
Shields et al.
Arch Ophthalmol 2005;123:109-113.
FULL TEXT  

Epiphora as a side effect of topical mitomycin C
Kopp and Seregard
Br. J. Ophthalmol. 2004;88:1422-1424.
ABSTRACT | FULL TEXT  

Treatment of Complex Choristoma by Excision and Amniotic Membrane Transplantation
Sangwan et al.
Arch Ophthalmol 2003;121:278-280.
FULL TEXT  

Population-Based Assessment of Clinical Characteristics Predicting Outcome of Conjunctival Melanoma in Whites
Tuomaala et al.
IOVS 2002;43:3399-3408.
ABSTRACT | FULL TEXT  

Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias
Espana et al.
Br. J. Ophthalmol. 2002;86:640-645.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Infection, Bcl-2, p53 Protein, and Ki-67 Analysis in Ocular Surface Squamous Neoplasia
Mahomed and Chetty
Arch Ophthalmol 2002;120:554-558.
ABSTRACT | FULL TEXT  

Conjunctival melanoma
Shields
Br. J. Ophthalmol. 2002;86:127-127.
FULL TEXT  

Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C
Shields et al.
Br. J. Ophthalmol. 2002;86:244-245.
FULL TEXT  

Conjunctival Melanoma: Risk Factors for Recurrence, Exenteration, Metastasis, and Death in 150 Consecutive Patients
Shields et al.
Arch Ophthalmol 2000;118:1497-1507.
ABSTRACT | FULL TEXT  

Malignant Melanoma Arising From Unusual Conjunctival Blue Nevus
Demirci et al.
Arch Ophthalmol 2000;118:1581-1584.
ABSTRACT | FULL TEXT  

Topical Mitomycin Chemotherapy for Conjunctival Malignant Melanoma and Primary Acquired Melanosis With Atypia: Clinical Experience With Histopathologic Observations
Demirci et al.
Arch Ophthalmol 2000;118:885-891.
ABSTRACT | FULL TEXT  

Malignant Melanoma of the Conjunctiva With Intraocular Extension
Wenkel et al.
Arch Ophthalmol 2000;118:557-560.
ABSTRACT | FULL TEXT  

Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil
Midena et al.
Br. J. Ophthalmol. 2000;84:268-272.
ABSTRACT | FULL TEXT  

Surgical Management of Conjunctival Melanomas
Francis et al.
Arch Ophthalmol 1999;117:1098-1099.
FULL TEXT  

Intraocular Neoplastic Cyst From Mucoepidermoid Carcinoma of the Conjunctiva
Gunduz et al.
Arch Ophthalmol 1998;116:1521-1523.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.